You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anlotinib

Showing 26 - 50 of 116
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type Trial in Shanghai (Anlotinib)

Completed
  • Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
  • Anlotinib
  • Shanghai, China
    Xinhua Hospital
Sep 13, 2021

Platinum-resistant Recurrent Clear Cell Ovarian Cancer Trial in Guangzhou (Niraparib, Anlotinib)

Not yet recruiting
  • Platinum-resistant Recurrent Clear Cell Ovarian Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Nov 21, 2021

Non-Small-Cell Lung Cancer Trial in Shanghai (Furmonertinib, Anlotinib)

Recruiting
  • Non-Small-Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Oct 14, 2021

MGMT-Unmethylated Glioblastoma Trial in Nanjing (Anlotinib, AK105, Radiotherapy)

Recruiting
  • MGMT-Unmethylated Glioblastoma
  • Anlotinib
  • +2 more
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Aug 27, 2021

Triple Negative Breast Cancer Trial in Guangzhou (Sintilimab, Anlotinib, Nab paclitaxel)

Recruiting
  • Triple Negative Breast Cancer
  • Guangzhou, Guangdong, China
    NeoSACT
Oct 9, 2021

Anlotinib for Esophageal Cancer (AFEC)

Recruiting
  • Esophageal Cancer
  • Anlotinib
  • Anyang, China
    Anyang Cancer Hospital
Jul 8, 2021

Anlotinib for Hepatocellular Carcinoma

Recruiting
  • Liver Neoplasms
  • Anlotinib
  • Nanning, Guangxi, China
    People's Hospital of Guangxi Zhuang Autonomous Region
Jun 29, 2021

Breast Cancer Trial in Guangzhou (Anlotinib)

Not yet recruiting
  • Breast Cancer
  • Anlotinib
  • Guangzhou, Guangdong, China
    Guangdong Women and Children Hospital
Jul 26, 2021

Head and Neck Squamous Cell Carcinoma Trial in Beijing (Pembrolizumab, Anlotinib)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospitial,Chinese Academy of Medic
Aug 2, 2021

Gastric Cancer Trial in Nanjing (BGB-A317, Anlotinib, Oxaliplatin)

Recruiting
  • Gastric Cancer
  • Nanjing, China
    The First Affiliated Hospital with Nanjing Medical University
Jul 5, 2021

Triple-negative Breast Cancer Trial in Chengdu (AT regimen, Tislelizumab, Anlotinib)

Recruiting
  • Triple-negative Breast Cancer
  • AT regimen
  • +2 more
  • Chengdu, Sichuan, China
    Department of breast surgery, Sichuan Provincial People's Hospit
Jul 18, 2021

Melanoma Trial in Changchun (Camrelizumab, Anlotinib, nab-Paclitaxel)

Recruiting
  • Melanoma
  • Changchun, Jilin, China
    The first hospital of Jilin University
Jul 27, 2021

Extensive Stage Small Cell Lung Cancer Trial in Fuzhou (Fluzoparil, Anlotinib)

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Fuzhou, Fujain, China
    Liu Zhenhua. ZhuangWu
Jun 17, 2021

Stereotactic Radiosurgery Combination With Anlotinib for Limited

Completed
  • Stereotactic Body Radiation Therapy
  • Anlotinib
  • Beijing, Beijing, China
    Department of Radiation Oncology Cancer Center, Peking Universit
May 31, 2021

NSCLC, Brain Metastases Trial in Guangzhou (Anlotinib)

Recruiting
  • Non-small Cell Lung Cancer
  • Brain Metastases
  • Anlotinib
  • Guangzhou, China
    Sun Yat-Sen University Cancer Center
Jul 20, 2021

Thyroid Cancer Trial in Shanghai (Anlotinib, surgery, core needle biopsy)

Active, not recruiting
  • Thyroid Cancer
  • Anlotinib
  • +2 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 30, 2021

Chronic Graft-versus-host-disease Trial in Shanghai (Anlotinib)

Terminated
  • Chronic Graft-versus-host-disease
  • Anlotinib
  • Shanghai, Shanghai, China
    Hematology Department
Mar 22, 2021

Gastric Cancer, Colo-rectal Cancer Trial in Beijing (Tislelizumab, Anlotinib)

Recruiting
  • Gastric Cancer
  • Colo-rectal Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Mar 2, 2021

Non Small Cell Lung Cancer Trial in Tianjin (Anlotinib, Icotinib)

Recruiting
  • Non Small Cell Lung Cancer
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Mar 12, 2021

SCLC, Extensive Stage, Lung Cancer, Small Cell Lung Cancer Trial in Chongqing (Toripalimab, Anlotinib, Cisplatin)

Recruiting
  • SCLC, Extensive Stage
  • +2 more
  • Chongqing, Chongqing, China
    Daping Hospital, Third Military Medical University
Feb 8, 2021

Stage III Adult Soft Tissue Sarcoma Trial in Shanghai (Pegylated liposomal doxorubicin, Anlotinib)

Recruiting
  • Stage III Adult Soft Tissue Sarcoma
  • Pegylated liposomal doxorubicin
  • Anlotinib
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 18, 2021

Metastatic Triple-Negative Breast Cancer Trial in Beijing (Anlotinib, Capecitabine)

Recruiting
  • Metastatic Triple-Negative Breast Cancer
  • Beijing, Beijing, China
  • +1 more
Dec 18, 2021

MGMT-Unmethylated Glioblastoma Trial in Hangzhou (Anlotinib)

Recruiting
  • MGMT-Unmethylated Glioblastoma
  • Anlotinib
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital of Zhejiang University School of
Jan 24, 2021

HER2-negative Breast Cancer, Gastric Adenocarcinoma, Cholangiocarcinoma Trial in Beijing (Niraparib, Anlotinib)

Not yet recruiting
  • HER2-negative Breast Cancer
  • +3 more
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Feb 18, 2021

NSCLC With EGFR Mutation, Locally Advanced Solid Tumor, Metastatic Cancer Trial in Shanghai (Osimertinib, Anlotinib)

Recruiting
  • Non-Small Cell Lung Cancer With EGFR Mutation
  • +3 more
  • Shanghai, Shanghai, China
    Shanghai Chest hospital
Feb 24, 2021